The Dana-Farber/Children’s Hospital Cancer Center (DFCHCC) provides the combined expertise of Boston Children's Hospital and the Dana-Farber Cancer Institute for the comprehensive medical and surgical care of both benign and malignant bone and soft tissue tumors in children and teens.
As one of the nation’s largest referral centers, and one of the few centers in the country with extensive experience in limb salvaging surgery, our renowned team of radiologists, pathologists, oncologists and surgeons collaborate to provide the best care possible for children with benign musculoskeletal tumors, and as well as comprehensive pediatric cancer treatment.
Our experts provide complete care for all tumors—whether benign or malignant—though diagnosis, treatment and follow-up, and use the latest diagnostic approaches to identify treatments that improve quality of life now and into adulthood.
Dana-Farber/Children’s Hospital Cancer Center offers a multidisciplinary treatment approach to care for each child. We provide long-term pediatric cancer treatment and support through Dana-Farber’s David B. Perini, Jr. Quality of Life Clinic.
Our pediatric surgeons are nationally recognized for their expertise in removing pediatric bone tumors and soft tissue tumors in children. We adhere to limb-sparing treatment whenever possible.
Whether your child’s tumor is benign or malignant, he or she will have access to experienced pediatric oncologists, orthopedists, radiotherapists, surgeons, pathologists, radiologists, nurses and psychosocial and physical therapy specialists all with a high level of expertise in benign and malignant bone and soft tissue tumors. They will work together to provide state-of-the-art, multidisciplinary care for your child. Because we are New England’s Phase I referral center for the Children’s Oncology Group—an international consortium of cancer treatment centers that conducts studies of pediatric cancers—we also offer clinical trials that are unavailable at other regional centers.
Advances in Care
Dana-Farber/Children’s Hospital Cancer Center was one of the first childhood cancer care centers in the country to use adjuvant chemotherapy and to perform limb salvage surgery for pediatric oncology patients with osteosarcoma, an aggressive bone tumor.
Most recently, our center has been involved in a long-term follow-up study to learn about quality of life and outcomes for limb salvage surgery, rotationplasty and amputation for children who have sarcoma of the lower leg. The team is also researching the effectiveness of non-invasive vs. open treatments for aneurysmal bone cysts.
Bone and soft tissue tumors form in the body’s connective tissue, which includes bone, cartilage, blood and fat. Some, but not all, of these tumors are malignant or cancerous, meaning they have the ability to spread to other parts of the body. Malignant tumors are often called sarcomas.
Combining the expertise of Dana-Farber Cancer Institute and Boston Children's Hospital, our Bone and Soft Tissue Tumor Program provides comprehensive medical and surgical care for children and adolescents with benign or malignant bone and soft tissue tumors.
As one of the first centers in the country to use adjuvant chemotherapy and perform limb salvage surgery for patients with osteosarcoma, we continue to offer a multidisciplinary treatment approach. Your child’s care team will include:
- orthopedic surgeons
- pediatric oncologists
- physical therapists
Here at Dana-Farber/Boston Children's Cancer Center, we consider you and your child integral parts of the care team and not simply recipients of care. You and your team will work together to customize a plan of care for your child.
The Bone and Soft Tissue Tumor Program treats children with the following benign and malignant conditions. For information on a particular condition, please select one from the list on the right.
Dana-Farber/Boston Children’s Cancer Center's oncologic and orthopedic surgeons are highly experienced in bone and soft tissue operations. If you are considering where to get treatment for your child, it’s important to know that outcomes are better when treatment is provided by surgeons with expertise in treating these conditions.